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Abstract
Background: There is an urgent need to measure phosphorylated cell signaling proteins in cancer tissue for the
individualization of molecular targeted kinase inhibitor therapy. However, phosphoproteins fluctuate rapidly following
tissue procurement. Snap-freezing preserves phosphoproteins, but is unavailable in most clinics and compromises
diagnostic morphology. Formalin fixation preserves tissue histomorphology, but penetrates tissue slowly, and is unsuitable
for stabilizing phosphoproteins. We originated and evaluated a novel one-step biomarker and histology preservative (BHP)
chemistry that stabilizes signaling protein phosphorylation and retains formalin-like tissue histomorphology with equivalent
immunohistochemistry in a single paraffin block.
Results: Total protein yield extracted from BHP-fixed, routine paraffin-embedded mouse liver was 100% compared to snap-
frozen tissue. The abundance of 14 phosphorylated proteins was found to be stable over extended fixation times in BHP
fixed paraffin embedded human colon mucosa. Compared to matched snap-frozen tissue, 8 phosphoproteins were equally
preserved in mouse liver, while AMPKb1 Ser108 was slightly elevated after BHP fixation. More than 25 tissues from mouse,
cat and human specimens were evaluated for preservation of histomorphology. Selected tissues were evaluated in a multi-
site, independent pathology review. Tissue fixed with BHP showed equivalent preservation of cytoplasmic and membrane
cytomorphology, with significantly better nuclear chromatin preservation by BHP compared to formalin. Immunohisto-
chemical staining of 13 non-phosphorylated proteins, including estrogen receptor alpha, progesterone receptor, Ki-67 and
Her2, was equal to or stronger in BHP compared to formalin. BHP demonstrated significantly improved immunohisto-
chemical detection of phosphorylated proteins ERK Thr202/Tyr204, GSK3-a/b Ser21/Ser9, p38-MAPK Thr180/Tyr182, eIF4G
Ser1108 and Acetyl-CoA Carboxylase Ser79.
Conclusion: In a single paraffin block BHP preserved the phosphorylation state of several signaling proteins at a level
comparable to snap-freezing, while maintaining the full diagnostic immunohistochemical and histomorphologic detail of
formalin fixation. This new tissue fixative has the potential to greatly facilitate personalized medicine, biobanking, and
phospho-proteomic research.
Citation: Mueller C, Edmiston KH, Carpenter C, Gaffney E, Ryan C, et al. (2011) One-Step Preservation of Phosphoproteins and Tissue Morphology at Room
Temperature for Diagnostic and Research Specimens. PLoS ONE 6(8): e23780. doi:10.1371/journal.pone.0023780
Editor: Veerasamy Ravichandran, Food and Drug Administration, United States of America
Received April 21, 2011; Accepted July 27, 2011; Published August 17, 2011
Copyright:  2011 Mueller et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by George Mason University, Inova Fairfax Hospital, the Istituto Superiore di Sanita, Italy, and a National Instituteso f
Health grant to LAL (R21CA125698-01A1) from the National Cancer Institute program ‘‘Innovations in cancer sample preparation’’. The funding agencies had no
role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions contained herein belong to
the authors and are not necessarily the official views of the funding agencies.
Competing Interests: The authors have read the journal’s policy and have the following conflicts: The technology discussed in this manuscript has been
developed under a National Institutes of Health (NIH) grant to LAL (R21CA125698-01A1) from the National Cancer Institute program ‘‘Innovations in cancer
sample preparation’’. Aspects of this technology, owned by George Mason University, have been submitted as a patent application on January 25, 2011 under the
title of ‘‘Improved One-Step Cell and Tissue Preservative for Morphologic and Molecular Analysis’’ (PCT/US11/22463), and some of the authors (CM, LAL, EFP, VE)
are co-inventors. This application is licensed by George Mason University to Theranostics Health, Inc., which is currently developing a product. LAL, EFP and VE are
stock holders of Theranostics Health, Inc. The authors adhere to the NIH and PLoS ONE policies on sharing data and materials.
* E-mail: cmuelle1@gmu.edu
Introduction
Protein kinase inhibitors constitute a large percentage of current
lead compounds for molecular targeted cancer therapy [1]. Pre-
clinical assessment of kinase inhibitors requires a comprehensive
elucidation of their on-target and off-target effects in tissue, rather
than cell lines, as well as an understanding of activated/
phosphorylated signaling pathways in individual patient tumor
specimens. Therefore, the ability to accurately quantify phosphor-
ylated proteins represents an urgent pre-clinical as well as clinical
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e23780need. Clinically, sub-populations of patients that may respond to
such targeted kinase inhibitors need to be identified for
individualization of therapy. Since the signaling pathways
constituting the drug targets are composed of post-translationally
modified proteins, this information cannot be directly obtained by
RNA transcript profiling. Consequently, accurate quantitative
measurement of the state of phosphoprotein cellular signaling
pathways directly in human diagnostic tissue samples will be a
critical driver for the future of molecular diagnostics [2].
Phosphoproteins are reactive in living tissue
Excised tissue is alive, and phosphoprotein signatures change
very rapidly during ‘‘cold ischemia time’’, when cells experience
the traumatic injury of excision and adapt to the absence of
vascular perfusion, ischemia, hypoxia, acidosis, accumulation of
cellular waste, absence of electrolytes, and temperature changes
[3,4]. In as little as 30 minutes post-excision, drastic changes occur
in the protein signaling pathways of the biopsy tissue [5]. In
response to wounding, cytokine release, vascular hypotensive
stress, hypoxia, and metabolic acidosis, a large surge of stress-
related, hypoxia-related, and wound repair-related signal pathway
proteins and transcription factors are induced in the tissue [6–8].
Depending on the processing delay time ex vivo, and reactive stage,
the activation/phosphorylation levels of cell signal proteins are
then elevated or suppressed in a manner which does not represent
the biomarker levels at the time of excision [5,9]. In fact, with
increasing sensitivity of analytical methodologies, an inherent
danger is measuring cell adaptations to ex vivo stresses as opposed
to measuring the in vivo state of cell signaling kinases. This critical
problem of pre-analytical variability is receiving specific attention
by the United States National Cancer Institute (NCI) through the
Office of Biorepositories and Biospecimen Research (OBBR),
which has found current tissue sample handling techniques to be a
major roadblock to future quality research and personalized
medicine [3].
The need for phosphoprotein preservation in a paraffin
block
Adequate preservation of phosphoproteins is required, if
accurate information about the state of protein signaling
architecture and drug target activation states at the time of
procurement are to be known. Currently, the only preservation
method routinely used to adequately preserve phosphoproteins is
snap-freezing in liquid nitrogen. However, low temperature (liquid
nitrogen or dry ice) freezing, shipping, and long-term storage is
expensive and is not available in many clinics. Freezing
compromises diagnostic pathology accuracy due to water crystal
formation that can disrupt cell membrane structure and osmotic
effects manifested as cell swelling/shrinkage (freezing artifacts).
Subdividing tissue, in which some tissue portions are set aside for
freezing and others are used for standard formalin fixation and
histology, is not desirable in the clinical diagnostic standard of care
due to tissue heterogeneity. Microscopic examination of the entire
biopsy specimen is required for accurate diagnosis [10]. Therefore,
several independent biopsies, that can be difficult and clinically
impossible to procure, must be collected from a single patient.
Consequently if tissue is removed for research, and not subjected
to histopathologic examination, vital diagnostic information may
be lost. The ideal solution would be for all diagnostic and
molecular analysis to be done on the same paraffin block of tissue.
Although a number of laboratories are therefore using formalin-
fixed, paraffin-embedded (FFPE) tissue for the evaluation of
phosphoprotein levels [11–13], previous studies have indicated
that the activation state of signaling proteins is not adequately
preserved in FFPE tissue [14,15]. This is not surprising, since the
formalin fixation process is slow and requires several hours of
fixation even for small core needle biopsies [16]. During this
fixation time period, the living cells are reacting ex vivo to stress and
rapidly change the underpinning protein-phosphorylation depen-
dent signaling networks from the in vivo biology to a signaling
architecture related to the ex vivo state.
The need for one-step room temperature preservation of
phosphoproteins and histomorphology transcends diagnostic pa-
thology to the broader research community. Preservation of
phosphoproteins and tissue morphology within the same piece of
tissuecould have the potential to be adopted by clinical pathologists,
biobanks, and open the way for parallel clinical diagnosis and
molecular analysis. Based on this critical need, we asked the
question if it is possible to stabilize phosphoproteins at room
temperature in a paraffin block with diagnostic quality tissue
morphology and preservation of protein antigenicity (Figure 1). To
this end we designed a novel fixative chemistry based on the initially
identified chemical principles required for an optimal phosphopro-
tein preservative [5]: (i) a combination of both kinase and
phosphatase inhibitors to immediately arrest both sides of the
kinase/phosphatase biochemical processes that occur continuously
inside the cell and tissue, (ii) permeation enhancers to decrease
penetration times into individual cells, (iii) a precipitating fixative
with reversible cross-linkers to cross-link proteins beyond the active
lifetime of the inhibitors, and (iv) an osmotically balanced buffer
with a carboxylic acid to maintain tissue/cell morphology during
fixation (Table 1). We previously demonstrated the successful
application of this preservation strategy as a transport medium for
downstream frozen tissue section applications [5]. However,
preservation of phosphoproteins in frozen tissue is only useful in a
research setting and is not applicable to routine medical practice or
field-based research. Consequently we further developed the initial
prototype phosphoprotein preservation chemistry as a solution
compatible with room temperature collection followed by subse-
quent paraffin embedding. We evaluated the state of protein and
post-translationally modified proteins from mouse, cat, and human
tissues fixed in our biomarker and histology preservative (BHP) for
(i) retention of phosphorylated levels over extended fixation time
and in comparison to snap-frozen material, (iii) overall yield of
extractable biomolecules, (iv) preservation of tissue morphology in
multiple organs and tissues, and (v) preservation of key diagnostic
immunohistochemistry antigens.
Results
Protein yield from BHP fixed paraffin embedded tissue
The amount of protein that can be extracted from small tissue
samples (i.e. core needle biopsies, laser capture microdissected
material, etc.) is a key limiting factor for many proteomic analysis
technologies.Adequatelypreservingtissuebiomarkersat the expense
ofdownstreamprotein recoverywouldthereforesubvertthepurpose
of tissue fixation. We compared the total protein yield from BHP-
preserved, paraffin-embedded tissue to matched samples that were
eithersnap-frozeninliquidnitrogenorparaffinembeddedafter10%
neutral buffered formalin fixation (hereafter referred to as formalin)
(Figure 2). Tissue sections were extracted in a volume of extraction
buffer that maintained a standard ratio of tissue area to buffer
volume. Tissue lysates were printed on reverse phase protein
microarrays [17,18]. Total protein was quantified on the reverse
phase protein microarray by Sypro Ruby Protein Blot staining.
After the application of a standard eight minute extraction
protocol, generally used for fresh frozen and/or microdissected
tissue [19], the yield of protein per tissue area was 36-fold higher in
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matched samples fixed in formalin. Since the time of formalin
fixation recommended by the American Society of Clinical
Oncology/College of American Pathologists for typical applica-
tions such as the HercepTest is 6–48 hours [20] and to address the
potential problem of overfixation, total protein was also extracted
from mouse brain fixed in formalin for one day, which decreased
the difference to 18-fold. Matched frozen brain tissue samples had
a 1.3-fold higher protein yield than seven day fixed BHP samples
and a 24-fold or 48-fold higher protein yield than one day or seven
day fixed formalin samples (Figure 2).
The protein yield from mouse liver was 14-fold higher from
tissue fixed for seven days in BHP compared to either one day or
seven day fixation in formalin. No difference in protein yield was
found between BHP fixed and frozen liver tissue.
To confirm if a higher extractability of protein from formalin
fixed tissue, comparable to that obtained with the BHP fixed
tissue, was possible using stronger extraction conditions, we slightly
modified a 60 minute protocol reported by Ostasiewicz et al. [13].
While BHP-fixed brain and liver tissue retained high levels of
extractable protein, the protein yield from one day and seven day
fixed formalin tissue increased to levels comparable to that
obtained by BHP fixed tissue (Figure 2, 60 minute protocol).
We were thus able to extract comparable levels of protein, using
a short eight minute extraction protocol, from samples fixed for 7
days in BHP to matched snap-frozen tissue samples, supporting
analysis with diagnostic or research specimens requiring short turn
around times.
Effect of BHP fixation time and tissue size on
phosphoprotein preservation
In a busy clinical environment the time period between sample
collection/start of tissue preservation (i.e. within the surgical
operating suite) and the paraffin embedding process (i.e. within the
Figure 1. Workflow for one step, room-temperature phosphoprotein preservation with subsequent paraffin embedding. A novel
tissue preservation solution, biomarker and tissue histology preservative (BHP), stabilizes phosphoproteins and cellular morphology at room
temperature. The application combines the unique advantages of snap-freezing (immediate and excellent preservation of phosphoproteins, as well
as high protein yield) and formalin fixation (preservation of tissue morphology and antigenicity) in one paraffin block.
doi:10.1371/journal.pone.0023780.g001
Table 1. Biomarker and Histology Preservative (BHP) composition.
Ingredient Function
Kinase inhibitors Inhibition of kinase activity
Phosphatase inhibitors Inhibition of phosphatase activity
Permeation enhancers Increased penetration rate into tissue/cells
Reversible crosslinkers Easily cleavable cross-linkage of proteins beyond the lifetime of inhibitors
Water based buffer solution Maintenance of tissue/cell osmotic balance and shape during fixation
Precipitating fixative Inhibition of enzymatic activity
Carboxylic acid Maintenance of tissue morphology
doi:10.1371/journal.pone.0023780.t001
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that the fixation process, which can take place over several days,
does not induce a selective shift in phosphoprotein abundance. We
collected 12 samples of colon mucosa from a 52 year old male of
which six were fixed for 48 hours in BHP, while the other six were
fixed in BHP for seven days, followed by paraffin embedding. We
then compared the level of 11 phosphorylated, 2 cleaved, and 10
non-phosphorylated proteins in all 12 samples (Figure 3). No
statistically significant difference (p.0.05) was found between
fixation times for any of the 23 proteins evaluated.
As recommended by clinical pathology guidelines [21], all
samples were cut into pieces of less than 1 cm
3 prior to fixation
and processing. To address the question whether differences in
tissue size would affect phosphoprotein preservation we correlated
the level of 11 phosphoproteins with the respective tissue size (mm
2,
as measured by the Arcturus
XT platform) in all 12 samples of
human colon mucosa described above. Spearman’s rho analysis
showed no correlation between tissue size and protein preservation
(p.0.05) (Figure S1 and Table S1), indicating that phosphoprotein
levels are independent of BHP fixation time and minor variations
in tissue size. Since all 12 samples originated from a single patient,
collection and processing times were equal between samples.
Comparison of phosphoprotein levels between patients
after BHP fixation
We extended our analysis of phosphoprotein preservation
between samples from different patients, where cellular composi-
tion, collection and processing times may not be exactly the same.
Slight architectural and molecular differences in the same tissue
from different patients could potentially result in variations in
fixative penetration rate and kinase/phosphatase inhibition, which
could lead to preservative induced alterations of phosphoprotein
levels. Using reverse phase protein microarrays [17,22], we
compared the abundance of 19 phosphorylated and non-
phosphorylated proteins in non-diseased human colon mucosa
from two patients with a history of colon polyps (patient A: female
age 45, and patient B: male age 56) (Figure 4A). Collection and
processing times were similar for both samples. Patient A tissue
was received 8 minutes after surgical excision. Tissue was
immersed in BHP fixative 16 minutes after receipt, for a total
elapsed time from collection of 24 minutes. Patient B tissue was
received 9 minutes after surgical excision. Tissue was immersed in
BHP fixative 14 minutes after receipt, for a total elapsed time from
collection of 23 minutes. Tissue was fixed for 24 hours prior to
paraffin embedding using an automated tissue processor with a
standard ethanol protocol. The pattern of protein abundance
between both patient samples was very similar and well within the
variation expected between two individuals, supporting equivalent
preservation of both samples.
Effect of BHP fixation on the phosphorylation of site-
specific residues on EGF receptor post EGF stimulation
The minute by minute state of active phosphoprotein signaling
pathways is a function of the dynamic and highly reactive
phosphorylation and de-phosphorylation of proteins in response
to external and internal stimuli. This fluctuating network needs to
be promptly and permanently frozen in time to allow meaningful
evaluation of cell signaling states. To evaluate the room
temperature preservation of dynamic protein phosphorylation
events, we stimulated U266 cells with epidermal growth factor
(EGF) for up to 30 minutes. EGF stimulation is expected to lead
to an increase in EGF receptor (EGFR) phosphorylation within
the first 10 minutes [18], followed by an attenuation of
phosphorylated receptor levels due to dephosphorylation, inter-
nalization, and degradation [23,24]. At 0, 10 and 30 minute time
points post stimulation cell aliquots were removed and lysed
immediately or fixed with either formalin or BHP for either 10
minutes or for two hours prior to cell lysis (Figure 5A).
Phosphoprotein levels were quantified by reverse phase protein
microarray [17,22]. As expected, EGFR phosphorylation at
tyrosine residue 1068 (EGFR Tyr1068) increased after 10
minutes of stimulation with EGF, while decreasing by 30 minutes
after continuous EGF exposure (Figure 5) [18]. The abundance of
total EGFR (phosphorylated and non-phosphorylated) did not
change during treatment (Figure 5C). Low levels of phospho-
EGFR Tyr1068 at 0 minutes, increased phospho-EGFR Tyr1068
after 10 minutes and decreased phospho-EGFR Tyr1068 were
also seen after BHP fixation. This exactly mirrored the pattern
observed when cell aliquots were not fixed after stimulation,
indicating stable preservation of dynamic phosphorylation
processes by BHP. In contrast, formalin fixation of cell aliquots
after stimulation induced a significant loss of phosphorylation,
with low levels of phospho-EGFR Tyr1068 at the 10 minute
stimulation time point. Similar protein concentrations of frozen,
BHP fixed and formalin fixed cell lysates were printed on the
array, therefore, the reduced signal intensity was not an artifact
due to differences in protein quantity. Reducing the formalin-
fixation time from two hours to ten minutes reestablished the
originally observed phosphorylation pattern of EGFR Tyr1068
(Figure 5), further indicating that it is in fact the prolonged
fixation by formalin that alters phospho-EGFR Tyr1068 levels.
This confirms that BHP fixation is capable of capturing the
dynamic phosphorylation pattern present in the cell at the time of
fixation, while formalin fixation may not preserve this informa-
tion adequately due to variations in fixation times.
Figure 2. Protein yield from BHP-fixed tissue is equivalent to
frozen tissue. Comparison of extractable protein yield from paraffin
embedded BHP-fixed and formalin-fixed mouse brain and liver tissue to
matched snap-frozen samples. Even after seven days of fixation in BHP
and using a short eight-minute extraction protocol the total protein
yield is very high compared to snap-frozen tissue. (white bar=formalin
fixed 1 day 6SEM; gray bar=formalin fixed 7 days 6SEM; black
bar=BHP fixed 7 days 6SEM).
doi:10.1371/journal.pone.0023780.g002
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One possible explanation for the difference in phosphoprotein
preservation by BHP and formalin was the retention of residual
phosphatase activity during formalin fixation. During the fixation
process phosphatase activity could lead to altered phosphorylation
levels that do not accurately mirror pre-fixed phosphoprotein
abundance. Using an ELISA we measured the total tyrosine
phosphatase activity in pieces of cultured breast tissue after 1, 5,
and 15 minutes of fixation with either BHP or formalin. One
minute of BHP fixation reduced the total tyrosine phosphatase
activity to 18% of non-fixed levels, while formalin fixed tissue
extracts retained 71% phosphatase activity (Figure 4B). After 15
minutes of fixation BHP preserved tissue showed complete
absence of tyrosine phosphatase activity, while phosphatase
activity in formalin fixed tissue was still at 29% of non-fixed
levels. It is therefore conceivable that residual phosphatase activity
in formalin fixed samples could lead to falsely decreased
phosphoprotein levels during tissue fixation (Figure 5).
Comparison of phosphoprotein levels between BHP fixed
and snap-frozen samples
Freezing is generally regarded as the standard protocol of
protein preservation. To evaluate room temperature preservation
of phosphoproteins in a paraffin block after BHP fixation, we
measured the relative abundance of nine phosphorylated proteins,
six non-phosphorylated proteins, one cleaved protein and single
stranded DNA in mouse liver (strain ICR/CDI) using reverse
phase protein microarrays (Figure 4C). Liver was selected for
Figure 3. Phosphoprotein and total protein levels are stable for one week in BHP fixative. Six aliquots of human colon mucosa were
either fixed for two or seven days in BHP and paraffin embedded. Reverse phase protein microarray analysis of 11 phosphoproteins, 10 total protein,
and 2 cleaved protein modification endpoints revealed no significant difference in protein abundance due to fixation time (open circle=2 day
fixation, black square=7 day fixation, Mann Whitney test, p.0.05).
doi:10.1371/journal.pone.0023780.g003
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minimizing any potential analytical artifacts due to tissue
heterogeneity. No significant difference was found for any of the
analytes. The exception was phosphorylated AMP-activated
protein kinase (AMPK) b1 Ser108, where slightly higher levels
were found after BHP fixation (Figure 4C).
One of the caveats of comparing snap-frozen tissue to fixed and
paraffin embedded tissue is the retention of blood and/or other
body fluid contaminants within the frozen tissue. These contam-
inants are largely washed away during the fixation and paraffin
embedding process. To determine the impact of residual blood on
the results of the frozen material, we also measured the abundance
of single stranded DNA (ssDNA). Since erythrocytes don’t possess
DNA, significant blood contamination would decrease the ratio of
ssDNA versus total protein amount. We observed comparable
ratios of ssDNA/total protein in fixed and frozen samples, which
indicates that a major impact on the data obtained from frozen
material by residual blood contamination is unlikely.
The almost identical phosphorylation pattern of snap-frozen
and BHP-fixed, paraffin-embedded tissue across nine phospho-
proteins (Figure 4C) supports the original hypothesis that room-
temperature preservation of phosphoproteins in a paraffin block is
possible.
Histology of paraffin embedded tissue fixed with BHP
The overarching goal of this study was the development of a new
tissue fixative that provided both room-temperature preservation of
phosphoproteins and diagnostic tissue histomorphology within the
same paraffin block. Since tissue structure, complexity, and cellular
composition vary greatly between tissue types we assessed the tissue
andcellularmorphologyafterBHPfixationandparaffinembedding
in over 25 different mouse, cat and human tissues (Figures 6 and 7,
Table S4, Text S1). Mouse tissues were selected for comparison
because the time of collection and processing could be controlled for
a comparative study whereas human biopsy specimens may exhibit
wide variability in collection/processing protocols. Formalin fixed
paraffin embedded matched tissues were selected for comparison
because a) formalin is routinely used in diagnostic pathology, and b)
a majority of archived tissue samples consist of FFPE tissues.
In general, comparison with matched FFPE tissue showed BHP
fixation achieved equivalent preservation of parenchymal, stromal,
epithelial, and lymphoid histomorphology with full preservation of
cell volume, cytoplasmic and membrane detail. Nuclear structures
(nuclear membrane, chromatin and nucleoli) were better pre-
served by BHP. This was especially striking in feline testes, where
chromatin strands were clearly visible after BHP fixation, whereas
nuclei in formalin fixed testes did not present any chromatin detail
(Figure 6, Text S1). Superior BHP preservation of nuclear
Figure 4. Evaluation of protein and phosphoprotein preserva-
tion by BHP fixation. (A) Slight tissue-architectural differences
between patients don’t appear to affect fixation efficiency by BHP.
The reverse phase protein microarray analysis of 19 endpoints in human
colon mucosa from two different patients revealed an almost identical
pattern of post-translationally modified and total protein abundances.
(B) BHP fixation rapidly reduces tissue tyrosine phosphatase activity.
Human breast tissue samples were directly lysed or fixed in BHP or
formalin for 1, 5 and 15 minutes prior to lysis. Residual total tyrosine
phosphatase activity was measured using an ELISA. After one minute of
BHP fixation phosphatase activity was reduced to 18% of non-fixed
levels and was completely absent by 15 minutes of fixation. In contrast,
formalin fixation retained 71% phosphatase activity after 1 minute of
fixation and 29% by 15 minutes of fixation. (n=2, black circle-formalin;
white square=BHP, dashed line non-fixed; 6SEM). (C) BHP fixation
followed by paraffin embedding yields comparable levels of post-
translationally modified and total protein in mouse liver tissue
compared to snap-frozen samples for 16/17 endpoints. Mouse liver
(n=3, 6SEM) was either paraffin embedded after fixing in BHP for
seven days or snap-frozen immediately and analyzed on a reverse
phase protein microarray (open circle=snap frozen; black square=BHP
7 day fixation).
doi:10.1371/journal.pone.0023780.g004
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eight human tissue samples (Figure 6, 7, 8, Table 2, Text S1).
BHP fixation obviates the need for decalcification of bony
tissues
Bony tissue presents a special challenge for molecular profiling
studies, since it cannot be cut into sections without being subjected
to harsh decalcifying conditions. Several methods of decalcification
have been shown to impair DNA and RNA recovery and reduce
antigenicity for certain antigens [25–28]. BHP fixation completely
eliminated the need for decalcification in 365 mm or smaller tissue
samples. Human bone marrow core biopsies as well as mouse tail,
rib, and femur were fixed inBHP,paraffin-embeddedand sectioned
with no limitations. Internal bone structures were well preserved,
including growth plates in mouse femur and rib, as well as bone
marrow trabeculae in human bone marrow cores (Figures 7 and 8,
Text S1). Equally treated formalin-fixed bony tissue could not be
sectioned properly, as shown in H&E stained sections of formalin-
fixed mouse tail (Figure 7, Text S1).
Effect of BHP fixation on nuclear size
A common phenomenon of ethanol-based fixatives is the
shrinkage of nuclei and cell volume after fixation [29]. Nuclei
shrinkage and loss of nuclear detail can severely compromise
diagnostic accuracy. Since BHP is a formalin-free fixation
chemistry that contains ethanol we measured the size of 50–100
nuclei in four different tissues to assess the effect of alcohol on
nuclear size and detail. After BHP fixation and paraffin
embedding, the average size of nuclei from human colon mucosal
epithelium cells, mouse brain purkinje neurons, and mouse liver
hepatocytes was fully maintained and slightly increased compared
to FFPE tissue. Mouse pancreas islet of Langerhans cells were
equal in size in the two fixation types (Figure 9).
Effect of BHP fixation on protein immunoreactivity
Immunohistochemical membrane, cyotplasmic and nuclear
protein antigenicity is a critical component of clinical diagnosis.
Without the preservation of antigenicity, along with tissue
morphology and phosphoprotein abundance, in the same paraffin
block, BHP fixation could not be applied to clinical diagnosis and
would not be accepted by clinical pathologists. To show that our
new fixation chemistry maintains antigenicity in human tissues for
common diagnostic antigens, we selected 14 non-phosphorylated
proteins, for analysis in an international, multi-center diagnostic
anatomic pathology laboratory study. Proteins representing
different sub-cellular locations were selected to show the
Figure 5. BHP fixation preserves dynamic changes in phospho-EGFR Tyr1068 abundance post stimulation. (A) Schematic of
experimental setup. U266 cells were continuously stimulated with EGF for 30 minutes. Cell aliquots at 0, 10 and 30 minutes were removed and
directly lysed or fixed in BHP or formalin prior to lysis. (B) After 10 minutes of fixation, BHP-fixed and formalin-fixed cells correctly maintain the
expected pattern of phospho-EGFR Tyr1068 increase and decrease that is observed in non-fixed cells. (C) While BHP-fixed cells still maintain the
expected phosphorylation pattern after two hours of fixation, this pattern is lost in formalin-fixed cells. (n=3, black diamond=formalin; black
square=BHP; open circle=non-fixed; 6SEM; error bars for the samples directly lysed after 30 minutes of EGF stimulation are very small and masked
by the open circle symbol).
doi:10.1371/journal.pone.0023780.g005
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evaluated Periodic Acid Schiff (PAS) and diastase-resistant PAS
stain as polysaccharide/mucin specific stains, to demonstrate the
compatibility of BHP fixed, paraffin embedded tissue with routine
immunohistochemical protocols. Although staining and embed-
ding protocols varied between institutions and for different
antigens, each institution used their specific protocol to stain the
matched formalin and BHP fixed tissues at the same time.
In general, IHC and special chemistry staining after BHP
fixation was equal to or stronger than formalin fixation, while
specificity of staining remained equally high (Figures 10 and 11A,
Figure S2, Tables S5 and S6, Text S1). This was especially
Figure 6. Comparison of tissue morphology between paraffin blocks of BHP-fixed or formalin-fixed mouse and feline tissue. BHP
fixed or fomalin fixed matched tissue sections were stained with Hematoxylin and eosin (H&E). BHP fixation demonstrates equivalent preservation of
cellular morphology with full cytoplasmic and membrane detail compared to formalin fixation. Nuclear structures (chromatin and nucleoli) are
generally better preserved by BHP (20x magnification, inset 100x) (Continued in Figure 7) (For description of histological details see Text S1).
doi:10.1371/journal.pone.0023780.g006
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human colon mucosal epithelial cells at the base of the crypt were
intensely stained after fixation with BHP, compared to very poor
staining after standard fixation with formalin. Cytokeratin 20
stained differentiated colon mucosal epithelial cells at the top of
the crypt [30] and smooth muscle actin (SMA) localized in the
smooth muscle layer of the colon mucosa, showed slightly stronger
immunoreactivity in BHP fixed tissue. Similarly, there were a
higher number of positively stained cells observed in uterine glands
for estrogen receptor alpha and progesterone receptor after BHP
Figure 7. Comparison of tissue morphology between paraffin blocks of BHP-fixed or formalin-fixed mouse tissue. In addition to
excellent preservation of cytoplasmic, membrane and nuclear detail, BHP-fixation eliminates the need for decalcification of bony tissue. Mouse tail,
rib, and femur samples were fixed in BHP and paraffin embedded without decalcification prior to embedding. Bony structures remain intact and were
able to be cut into sections (5 mm) using standard sectioning protocols (H&E stain, 20x magnification, inset 100x) (For description of histological
details see Text S1).
doi:10.1371/journal.pone.0023780.g007
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showed excellent preservation of acidic mucin (blue) and
polysaccharides (magenta) within the vacuoles of the colonic
mucosal goblet cells [31]. To evaluate membrane protein staining
we applied the HercepTest (Dako) to human ductal carcinoma in-
situ (DCIS) and normal breast tissue. Tissue sections were less than
5 mm, and were immersed in a sufficient volume of fixative to
allow adequate tissue penetration [20,32]. Stronger membrane
staining was observed in BHP than FFPE-fixed DCIS tissue, while
normal tissue showed negative staining for both fixation
chemistries (Figure 10, Text S1).
Our observation of more intense immunostaining in BHP
compared to formalin fixed tissues raises the question of antigen-
antibody specificity. This is especially true for clinical tests, such as
Figure 8. Human tissue fixed in BHP retains morphology equivalent to formalin. Matched human tissue samples were fixed in either BHP
or formalin and paraffin embedded. The same pattern as seen for mouse and feline tissues (see Figures 5 and 6) were observed for human tissue fixed
in the one-step biomarker and histology preservative: equivalent preservation of cytoplasmic and membrane detail, with superior preservation of
nuclear structures as compared to matched formalin fixed paraffin embedded tissue (H&E stain, 20x magnification, inset 100x) (For description of
histological details see Text S1).
doi:10.1371/journal.pone.0023780.g008
Table 2. Independent evaluation of human colon mucosa by two pathologists.
Criteria Worse than FFPE Equal to FFPE Better than FFPE
Overall color fidelity x
Cell size x
Preservation of nuclear membrane x
Preservation of nucleoli x
Preservation of overall cell structure x
Nuclear:Cytoplasmic ratio maintained x
BHP-fixed, paraffin-embedded tissue compared to formalin-fixed, paraffin-embedded (FFPE) tissue.
doi:10.1371/journal.pone.0023780.t002
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where the clinical diagnosis has a profound impact on patient
treatment and prognosis. To evaluate the specificity of the intense
immunostaining seen in BHP-fixed tissue we performed a protein
competition assay with the HercepTest antibody, in which the
HercepTest antibody was incubated with full-length Her2 protein
prior to analysis. No staining was visible after the protein
competition, indicating that the more robust Her2 staining seen
in BHP-fixed DCIS breast tissue is specific and not due to
secondary antibody reactivity or non-specific interactions (Figure
S2). Of all antigens investigated, only CDX2 showed a slightly
reduced staining intensity based on independent pathologist
observations (Tables S2 and S3).
We further evaluated the preservation of antigenicity for 6 labile
phosphorylated proteins that are of special relevance to cancer
biology: ERK Thr202/Tyr204, GSK3 a/b Ser21/Ser9, p38
MAPK Thr180/Tyr182, eIF4G Ser1108, Acetyl-CoA Carboxyl-
ase Ser79 and Bcl-2 Ser70 (Figure 11A (data for Bcl-2 not shown),
Table S6, Text S1).
In each case staining was significantly stronger after BHP
fixation compared to formalin fixation. In the cases of phospho-
ERK Thr202/Tyr204 in human colon cancer, phospho-GSK3 a/
b Ser21/Ser9 in human DCIS, phospho-p38 MAPK Thr180/
Tyr182 in mouse brain cortex and phospho-acetyl-CoA carbox-
ylase Ser79 in mouse brain hippocampus, staining was virtually
absent in formalin fixed samples, but clearly visible in matched
BHP fixed tissue.
To evaluate the effect of long term fixation with BHP on the
retention of tissue antigenicity, we fixed human colon mucosa for
three months in BHP prior to paraffin embedding. As demon-
strated by strong staining for phospho-ERK Thr202/Tyr204 and
cytokeratin 20, antigenicity for phosphorylated and non-phos-
phorylated proteins was apparently fully retained (Figure 11B,
Text S1).
Discussion
Room temperature preservation of phosphoproteins is a
necessity for molecular profiling
At the functional level cancer pathogenesis is influenced by
differential activation/deactivation of cellular signaling networks
that are enzymatically modulated by posttranslational modifica-
tion of proteins by kinases and phosphatases. A high proportion of
the current phase I–III drug pipeline for cancer therapy are
Figure 9. Nuclear size is maintained in tissue fixed with the novel biomarker and histology preservative. The nuclear area of BHP-fixed
or formalin-fixed and paraffin-embedded human colon mucosa, mouse brain purkinje cells, mouse liver hepatocytes and mouse pancrease islet of
Langerhans cells was measured using the Arcturus XT platform (n=50–100). No shrinkage in nuclear size was observed after BHP fixation. (white
bar=formalin; black bar=formalin 6SEM).
doi:10.1371/journal.pone.0023780.g009
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activity of kinases and phosphatases directly in human biopsy
tissue in order to match the correct targeted thearpy with each
patient’s unique signaling architecture. Nevertheless, phosphopro-
tein biomarkers will not achieve their expected clinical impact
unless the significant physiologic and technological barriers to
Figure 10. Biomarker and histology preservative shows equivalent or enhanced antigenicity by immunohistochemistry compared
to FFPE. To show that our new fixation chemistries maintains antigenicity for common diagnostic antigens, the effect of BHP fixation on non-
phosphorylated protein antigenicity was compared in human tissue fixed in BHP or formalin and paraffin embedded in an international, multi-center
study. At each institution, sections were stained side-by-side, using the same protocol for each fixative. Staining and embedding protocols varied
between institutions and for different antigens. Antigenicity was stronger for most endpoints in BHP-fixed tissue, with the exception of CDX2 (SMA =
smooth muscle actin, ERa = estrogen receptor alpha, PR = progesterone receptor, PAS = Periodic Acid Schiff stain, DCIS = ductal carcinoma in-situ,
DLBCL = diffuse large B-cell lymphoma, LN met/col. canc. = lymph node metastasis from colon cancer) (For description of histological details see
Text S1).
doi:10.1371/journal.pone.0023780.g010
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and stabilization are overcome.
Excised tissue is alive, and the cells therein experience a host of
traumatic changes to their new environment, including the
absence of vascular perfusion, ischemia, hypoxia, acidosis and
accumulation of cellular waste. We have previously demonstrated
that within 30 minutes after procurement protein phosphorylation
changes dramatically in clinical tissue specimens [5]. Only the
specific and rapid preservation of phosphoproteins can therefore
yield information representative of the in vivo state of the signaling
network within the tissue at the time of excision. Ideally this
preservation should be compatible with morphologic examination
and paraffin embedding similar to the standard practice of using
FFPE. Such a preservation system will enable the same high
degree of molecular and morphologic analysis to be applied to
diagnostic samples as well as research samples. Rapid, controlled
temperature elevation to inactivate enzymatic activity in tissue has
been found to preserve phosphoproteins in mouse heart and brain
analyzed by liquid-based techniques such as electrophoresis and
mass spectrometry [33–35]. Although thermal treatment effec-
tively inhibits enzymatic activity, it fails to preserve cellular
morphology. Formalin, on the other hand, preserves tissue
Figure 11. BHP fixed tissues retain phosphoprotein antigenicity with immunhistochemistry. (A) Effect of BHP fixation on phosphorylated
protein antigenicity. Human and mouse tissues were fixed with BHP or formalin, followed by paraffin embedding. Sections were stained side-by-side,
using the same protocol for each fixative. Staining intensity with phospho-specific antibodies was stronger after BHP fixation for every analyte tested.
(B) Effect of long-term BHP fixation on protein antigenicity. Human colon was fixed for three months in BHP, followed by paraffin embedding. Specific
and strong staining was observed for phospho-ERK Thr202/Tyr204 and cytokeratin 20, indicating retention of antigenicity for immunohistochemical
studies (For description of histological details see Text S1).
doi:10.1371/journal.pone.0023780.g011
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block - but lacks adequate phosphoprotein preservation properties
[14,15]. These deficiencies of formalin are more than tissue-based
penetration related issues as we have shown that formalin failed to
preserve an EGF induced increase in the phosphorylation of
EGFR Tyr1068 in suspension cells that are likely immediately
fixed, thus indicating inadequate retention of phosphorylation due
to the slow inhibition of phosphatase enzymes (Figure 5). One may
assume that adding a phosphatase inhibitor to formalin could
overcome this shortcoming. Unless phosphatases and kinases are
adequately inhibited, retention of kinase activity, in the absence of
phosphatase activity, will result in falsely elevated phosphoprotein
levels [5].
Although alternative fixation chemistries to formalin have been
developed [36–38], none address the specific need for one-step,
room temperature preservation of phosphoproteins and tissue
histomorphology in a single paraffin block. We designed a novel
fixation chemistry, based on our previous observations related to
the need to inhibit both phosphatases and kinases in tissue samples
prior to tissue processing [5,9]. The study presented herein
demonstrates the feasibility of combining room-temperature
preservation of phosphoproteins with retention of tissue histomor-
phology in a paraffin block (Table 1). This new fixative
formulation also incorporated reagents to address less appreciated
aspects of tissue fixation, such as infectious agent inactivation or
attenuation, which can be accomplished with denaturing and
cross-linking fixatives [37].
Merits of current fixation/preservation methods
One advantage of snap-freezing over formalin fixation is the
ease of protein extractability from frozen samples. Formalin
fixation causes permanent cross-linkage between amino groups
[39], which renders the extraction of full-length proteins very
difficult. Using a standard protein extraction protocol for small
tissue samples (e.g. laser capture microdissected material or core
needle biopsy tissue sections) [19], mouse liver tissue fixed in
formalin for one day followed by paraffin embedding yielded 13
times less protein per tissue area than matched snap-frozen tissue.
In contrast, the total protein yield from tissue fixed with BHP for
seven days followed by paraffin embedding was equal to snap-
frozen tissue. Only after adopting a strong extraction buffer in a
much longer extraction protocol were we able to increase the
protein yield from FFPE tissue to levels with frozen tissue.
Another advantage of snap-freezing is the speed at which
ongoing enzymatically-driven biochemical reactions are halted.
Cellular kinase and phosphatase activity are rapidly inhibited (less
than one minute) when cells are frozen in liquid nitrogen and the
in vivo state of the cellular signaling architecture is not altered
because of the change in the cellular environment. We speculated
that the slow speed of formalin fixation could contribute to its
limited success in preserving protein phosphorylation levels.
Although formalin penetrates tissue at about 1 mm/h [40] the
actual fixation process is much slower, requiring fixation times of
eight hours or more, depending on tissue type and size [41]. We
were able to show that protein tyrosine phosphatases are active for
at least 15 minutes after inserting a small piece of breast tissue
(1 mm
3) into formalin. During this time the cell is reacting to ex vivo
stresses, altering cell signaling patterns in reaction to the toxic
stress of fixation. Supporting a direct effect of formalin fixation on
phosphoprotein signaling, we found that an EGF-induced
phosphorylation peak of EGFR Tyr1068 in U266 cells suspended
in formalin, was not adequately preserved (Figure 5). This is in
agreement with previous studies that have already indicated that
the level of phosphoproteins is not adequately preserved in FFPE
tissue [14,15] and supports the concern that molecular analysis
performed with FFPE tissue may skew phosphoprotein results.
In contrast to formalin, BHP fixation reduced the total tyrosine
phosphatase activity in breast tissue to 18% after one minute of
fixation, with no residual phosphatase activity observed by 15
minutes. This speed of phosphatase inhibition translated directly
into the preservation of the expected increase in EGFR Tyr1068
phosphorylation after EGF stimulation of U266 cells. Even though
the measurement sensitivity of reverse phase protein microarrays is
very high (femtomolar range) [17,22] no significant difference
between snap-frozen tissue and BHP fixed, paraffin-embedded
tissue was found in 9/10 phosphoproteins evaluated in paraffin
embedded mouse liver, except for a slight increase in phospho-
AMPKb1 Ser108 (Figure 4C). AMPK is activated by cellular
stress, such as hypoxia or ischemia, through an increased ratio of
AMP:ATP (for review, see [42]). AMPK consists of a heterotrimer
with a catalytic a unit and regulatory b and c units.
Phosphorylation at Ser108 of the b1 unit of AMPK is required
for enzyme activation [43]. Its slight elevation could indicate a
cellular response to the cytotoxic fixation process, or an improved
exposure of the AMPK antigenic epitope. If AMPK elevation were
due to a toxic reaction of the cell to BHP, we would expect that
reactive changes would have been observed in other phosphopro-
teins. This was not the case.
We further demonstrated that the fixation process itself does not
progressively alter phosphoprotein levels, even if samples were
fixed for as long as one week before paraffin embedding. This is
important, since the time from tissue collection to paraffin
embedding may fluctuate over several days due to weekends,
holidays, or the necessity to ship fixed samples to external facilities
for processing. Also, inter-patient differences in tissue architecture
did not significantly impact phosphoprotein preservation, as
shown for two cases of highly labile human colon mucosa from
two different patients that had nearly identical phosphoprotein
patterns after fixation and paraffin embedding (Figure 4A).
Together, this supports our hypothesis that room temperature
preservation of phosphoproteins and their intrinsic activation
portraits in a paraffin block is possible. It is estimated that about
100–120 million proteins per cell are involved in signal
transduction [44,45], while about 33% of proteins are phosphor-
ylated at any given time [45]. Here, we have focused on a subset of
phosphoproteins selected to cover (i) several subcellular locations
(membrane receptors, cytoplasmic proteins, cytoskeletal proteins
and nuclear transcription factors), (ii) key functional signaling
pathways (hypoxia, oxidative stress, growth/proliferation, apop-
tosis) and (iii) the amino acids at which the majority of
phosphorylations occur (serine, threonine, tyrosine). We further
based our selection on targets that were found to be reactive in
previous phosphoprotein stability timecourse experiments [5].
Based on our current observations using the described represen-
tative selection of phosphoproteins, it is feasible to collect tissue
using BHP for cell signaling based pathway mapping analysis –
even when freezing is not an option. Future studies will be
necessary to extend the evaluation of the described technology to
additional phosphoprotein targets and signaling pathways.
Clinical application requires preservation of tissue
morphology and antigenicity
For clinical utility, a room-temperature phosphoprotein preser-
vative has to overcome the limitations posed both by formalin (i.e.
limited preservation of phosphoproteins and limited extractable
biomolecule yield), and freezing (i.e. lack of availability in clinical
laboratories and impairment of tissue morphology), while
maintaining diagnostic quality morphology. We have compared
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FFPE, the most widely used preservative for tissue structure and
cellular components [41]. In over 20 different human, mouse and
feline tissues, BHP fixation showed equivalent preservation of
morphology with full cytoplasmic and membrane detail, as well as
better preservation of nuclear structures (chromatin and nucleoli)
than matched FFPE tissues. Nuclear size was maintained in
human colon mucosa epithelial cells, mouse brain Purkinje cells,
mouse liver hepatocytes, and mouse pancreas islet of Langerhans
cells. The finding that nuclear structure and size was equivalent to
formalin fixed paraffin embedded tissue is a significant finding if
the fixative is to be used for diagnostic pathology. Osmotic
changes induced by alcohol-based fixatives can often cause cell
shrinkage, thus limiting their application for diagnostic specimens.
Modifications to alcohol based fixatives, such as addition of
trehalose [46] or glycine [36] have mitigated some of these ethanol
artifacts.
Professional socities such as the American Society of Clinical
Oncologists (ASCO) and the College of American Pathologists
(CAP) advocate standardized, reproducible immunohistochemical
analysis of FFPE tissue samples for Her2, ER and PR clinical
diagnositic assays [20,32]. Although the Her2 testing guidelines
stipulate using only FFPE tissue samples fixed for 6–48 hours,
scant literature evidence exists for the exclusive use of FFPE
samples or longer fixation times [47–49]. In our immunohisto-
chemical and microarray comparisons between our biomarker and
histology preservative and formalin, we did not adjust antibody
concentrations (primary or secondary antibodies) or antigen
retrieval methods. Some antibodies routinely used in IHC
recognize cross-linked forms of the protein with higher affinity
than native forms. Any future/current non-formalin fixation
chemistry may benefit from optimization of reagent parameters.
Decalcification of bony tissues was a serendipitious discovery
related to propeties of the biomarker and histology preservative.
Decalcification is usually accomplished using strong acid (formic
acid) or chelating agents (EDTA), which disrupts morphology,
alters antigenicity, and is time consuming. Molecular profiling in
bony tissues, such as bone metastasis or inner ear structures, has
been hindered by the ability to measure phosphoproteins and
nucleic acids in decalcified samples [25–28].
A primary goal of this study included making observations
regarding preservation of key diagnostic immunohistochemical
antigens. Ki-67, estrogen receptor alpha, progesterone receptor and
HER2 where fully preserved in BHP fixed tissue. In fact, Ki-67
staining was greatly enhanced after BHP fixation. Ki-67 strongly
stained proliferating human colon mucosal epithelial cells at the
base of the crypt, whereas poor staining was observed after standard
fixation in formalin processed in parallel with the BHP fixed tissue.
Antigen-antibody specificity is an essential element of immunohis-
tochemistry,therefore anyfixative orfixationprocess mustmaintain
the antigens in a state compatible with diagnostic assays. As shown
using a Her2 antibody competition assay, HercepTest staining in
BHP-fixed DCIS breast tissue was highly specific (Figure S2)
demonstrating the utility for research specimens.
Of 14 non-phosphorylated protein antigens tested, only CDX2
showed a weaker than expected staining. All phosphoprotein
antigens evaluated stained stronger after BHP fixation, which can
greatly facilitate future phosphoprotein-targeted immunohisto-
chemistry. For example, Acetyl-CoA Carboxylase Ser79 staining
was visible in mouse brain hippocampus cell processes where no
staining was seen after formalin fixation. In this instance,
assessment of Acetyl-CoA Carboxylase phosphorylation levels
would have been inaccurately described as negative if FFPE tissue
had been analyzed.
Conclusions
Preserving labile tissue phosphoproteins and full diagnostic
histomorphology at room temperature in a paraffin block removes
a critical roadblock to the realization of individualized therapy.
Herein, we present data demonstrating that we have developed and
successfully applied a formalin-free phosphoprotein preservation
chemistry to room-temperature usage, combined with paraffin
embedding. The special attribute of this technology is the
combination of (i) the rapid stabilization of the phosphoprotein
signature by simultaneous inhibition of kinase and phosphatase
activity; (ii) the compatibility with standard paraffin embedding,
obviating the need for freezing; (iii) the preservation of diagnostic
histomorphology; (iv) the significantly improved yield of total and
phosphoprotein analyte molecules extracted from the tissue; and (v)
the compatibility with downstream analytical methods such as
immunohistochemistry, reversephase protein microarrays, Western
blots and ELISA. This technology has the potential to facilitate
individualized therapy based on the measurement of phosphoryla-
tion-driven cellular signaling events. Large-scale validation of this
preservation technology is warranted to obtain cross platform
comparisons with current methodologies and to establish its
applicability to a wide range of phosphoprotein and immunohis-
tochemical targets.
Materials and Methods
Ethics Statement
Animal studies were carried out in strict accordance with the
r e c o m m e n d a t i o n si nt h eG u i d ef o rt h eC a r ea n dU s eo fL a b o r a t o r y
Animals of the National Institutes of Health. The protocol was
approved by the George Mason University institutional animal care
andusecommittee(Number:0176).Alltissuesamplesweretakenasa
terminal event post euthanasia, and all efforts were made to minimize
suffering. Feline testis tissue from a privately owned pet was obtained
with owner’s consent during a routine neutering operation.
Human surgical tissue specimens were collected from patients
under written informed consent following the protocols by the
Mediterranean Institute of Oncology Internal Ethical Review
Board (samples 13–16 (Table S7)) or the institutional review
boards of Inova Fairfax Hospital and George Mason University
(all other samples (Table S7)). Tissue was excised in the surgical
suite following standard of care guidelines. Tissue was transported
at room temperature to the surgical frozen section room. A board-
certified pathologist performed gross examination of each tissue
sample and provided non-diseased and/or diseased tissue that was
not required for diagnosis.
Fixative preparation and use
The biomarker and histology preservative (BHP) was prepared
from a combination of a precipitating fixative, a permeation
enhancer, a carboxylic acid, phosphatase and kinase inhibitors,
and reversible cross linkers (Table 1) (patent application PCT/
US11/22463). In short, the carboxylic acid (Sigma-Aldrich) was
solubilized in a water based buffer solution (Thermo Fisher
Scientific). Afteraddition of ethanol(Sigma-Aldrich), the permeation
enhancers (Thermo Fisher Scientific), as well as phosphatase
inhibitors (Calbiochem; Sigma-Aldrich) and kinase inhibitors
(Sigma-Aldrich; Enzo Life Sciences) were mixed into the solution.
Finally, reversible cross linkers (Thermo Fisher Scientific) were
addedtocompletethefixative.Thedescribedfixativesolutionwillbe
commercially available throughTheranostics Health,Inc.Toensure
reproducibility of the described data, the authors are happy to
provide BHP for evaluation purposes prior to commercialization of
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Claudius Mueller at cmuelle1@gmu.edu).
Tissue samples were immersed into the fixative and kept at room
temperature until paraffin embedding (if applicable) (Table S7).
Tissue preserved in BHP was processed using standard ethanol-
based tissue processing protocols by commercial histology laborato-
ries (AML Laboratories, Baltimore, MD or HSRL Mt. Jackson, VA)
or aclinicaldiagnosticpathologylaboratory(Mediterranean Institute
of Oncology, Italy; samples 13–16 (Table S7)) with no contact to
formalin-containing solutions. Tissue wasprocessed directly from the
BHP fixative without being placed in 70% ethanol as was the case
with formalin fixed tissue samples. Samples were processed through
graded ethanol (70%, 95%, and 100%), cleared in xylene, and
embedded in Paraplast paraffin (Mercedes Medical) or McCormick
Paraplastplus(LeicaMicrosystem;samples13–16(TableS7)).Tissue
fixed in 10% neutral buffered formalin was processed through
formalin and also embedded in Paraplast paraffin.
Mouse tissue acquisition and preservation
Mouse tissue was collected from NOD SCID, C57BL/6, DBA/
2J and ICR/CDI mouse strains. Mice were housed according to
standard animal care procedures with water and chow provided ad
libitum. After euthanasia with CO2, organs were dissected and
tissues immersed in BHP, 10% neutral buffered formalin or snap-
frozen in liquid nitrogen within 15 minutes of euthanasia (Table
S7). Paraffin embedding and sectioning was performed at either
AML Laboratories (Baltimore, MD, USA) or HSRL (Mt. Jackson,
VA, USA). Tissue fixed in 10% neutral buffered formalin was
processed through formalin, while BHP-fixed tissue was processed
using standard ethanol-based tissue processing protocols with no
contact to formalin-containing solutions.
Human tissue acquisition and preservation
Patients undergoing surgical procedures in a community hospital
(Inova Fairfax Hospital, Fairfax, VA or Mediterranean Institute of
Oncology, Catania, Italy) were enrolled and written informed
consent was obtained for participation in an IRB approved research
protocol according to the Declaration of Helsinki. Tissue was
excised in the surgical suite following standard of care guidelines.
Tissue was transported at room temperature to the surgical
pathology grossing room, where a board certified pathologist or
physician assistant performed gross examination of each tissue
sample and provided tissue that was not required for diagnosis.
Tissue was cut into uniform pieces less than 5 mm65 mm, and
immediately submerged in BHP or 10% neutral buffered formalin.
Tissue processing/embedding was performed on site using a Leica
ASP 3000 automated system (samples 13–16 (Table S7)) or by a
commercial histology service (AML Laboratories, Baltimore, MD
or HSRL, Mt. Jackson, VA). Tissue fixed in 10% neutral buffered
formalin was processed through formalin, while BHP-fixed tissue
was processed using standard ethanol-based tissue processing
protocols with no contact to formalin-containing solutions.
Human bone marrow core biopsies were collected following an
IRB approved research protocol, with written informed consent,
from patients undergoing a bone marrow aspirate as part of a
diagnostic work-up for multiple myeloma. The core biopsy was
collected from the posterior iliac crest using a trephine needle. The
biopsy was placed immediately into an aliquot of BHP at room
temperature.
Protein extraction from frozen and paraffin embedded
tissue
Whole slide lysates of paraffin embedded tissue were depar-
affinized in two changes of xylene for 15 minutes each, rehydrated
in graded alcohols (100%, 95%, 70%) and air dried prior to
protein extraction. The tissue area was estimated by outlining a
representative image of a serial section of each sample using a
polygon drawing software option with the ArcturusXT laser
capture microdissection instrument (Life Technologies, Carlsbad,
CA) and calculating the resulting polygon area. Whole tissue
sections were scraped off with a clean razor blade and added to a
volume of extraction buffer based on the area of each tissue
section. Frozen tissue was sectioned in a cryostat (5 mm) and
directly added to a microcentrifuge tube with a volume of
extraction buffer based on the area of the tissue section.
Two different extraction protocols were applied. Gentle
extraction conditions (extraction protocol 1) consisted of an
extraction buffer made of a 10% (v/v) solution of Tris(2-
carboxyethyl)phosphine (TCEP; Pierce, Rockford, IL) in Tissue
Protein Extraction Reagent (T-PER
TM, Pierce)/2X SDS Tris-
glycine buffer (Invitrogen, Carlsbad, CA) [19]. Protein lysates were
incubated at 100uC for 8 minutes. Strong extraction conditions
(extraction protocol 2) were adapted from Ostasiewitz et al. [13].
In short, samples were incubated at 100uC for 60 minutes with
vortexing every 10 minutes in an extraction buffer consisting of
4% SDS (Research Products International, Mt. Prospect, IL) and
100 mM DTT (Thermo Fisher Scientific, Pittsburgh, PA) in a
100 mM Tris-HCl solution (Bio-Rad, Hercules, CA) at pH 8.
Samples were frozen at 280uC until analysis.
Cell culture and cell lysis extracts
U266 cells were cultured to 80% confluence with appropriate
medium supplemented with fetal bovine serum and spun at 300 x
g for 5 minutes at room temperature. The cells were resuspended
in 12 mL of medium and distributed equally into 3 aliquots. To
measure unstimulated levels of phospho-epidermal growth factor
receptor (EGFR) Tyr1068, 200 mL of cell suspension was spun at
800 x g for 3 minutes and washed with phosphate buffered saline
without calcium or magnesium (PBS) (Gibco). This was repeated
once and then either 100 mL of BHP or 10% neutral buffered
formalin was added. For direct cell lysis, extraction protocol 1 was
applied (see above). After fixation for 10 minutes or 2 hours
extraction protocol 1 was applied to lyse cells. To stimulate
epidermal growth factor (EGF) receptor phosphorylation cells
were incubated with 200 ng/mL human EGF (Cell Signaling,
Danvers, MA) for up to 30 minutes. Cell aliquots were removed
from the suspension and either directly lysed or fixed and lysed as
described above after 10 minutes and 30 minutes of stimulation.
Protein extracts were frozen at 280uC until printing on reverse
phase protein microarrays [17,22].
Reverse Phase Protein Microarray (RPMA) construction
and staining
Reverse phase protein microarrays (RPMA) are a technology
platform designed for quantitative, multiplexed analysis of cellular
proteins. With very minimal volume requirements RMPA achieve
high sensitivity (femtogram to attogram range) and good precision
(,15% CV intra- as well as inter-assay), which makes them critical
methodological components for several clinical trials [2]. Cellular/
tissue lysates were printed on glass backed nitrocellulose array
slides (Schott, Lexington, KY) using an Aushon 2470 arrayer
(Aushon BioSystems, Burlington, MA) equipped with 350 mmo r
185 mm pins as previously described [2]. Serial two-fold dilutions
of bovine serum albumin (concentration 1.0 mg/mL) were printed
on the arrays as a total protein standard. RPMA staining was
performed on a Dako Autostainer per manufacturer’s instructions
(CSA kit, Dako). Each slide was incubated with a single primary
antibody at room temperature for 30 minutes (for antibody details
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negative control (secondary antibody only) microarrays were
baked for 2 hours at 80uC prior to blocking, with no Re-Blot
(Millipore, Billerica, MA) incubation. Antibodies were validated by
western blotting as previously described [18]. In addition a
phospho-ERK Thr202/Tyr204 specific western blot was per-
formed using frozen and BHP-fixed human colon mucosa to
determine the compatibility of BHP fixation with downstream
western blotting as well as unaltered phosphoprotein band
morphology and specificity compared to frozen tissue (Figure
S3). The negative control slide was incubated with antibody
diluent. Secondary antibody was goat anti-rabbit IgG H+L
(1:10,000) (Vector Labs, Burlingame, CA). Subsequent signal
detection was amplified via horseradish peroxidase mediated
biotinyl tyramide deposition with chromogenic detection (Diami-
nobenzidine) per manufacturer’s instructions (Dako). RPMA
images were captured with a flat bed scanner at 600 dpi
(350 mm pins) or 1200 dpi (185 mm pins) resolution. Signal
intensity for each spot/array was determined with ImageQuant
ver5.2 (GE Healthcare, Piscataway, NJ). RPMA intensity data was
either normalized to total protein content or beta actin levels.
Total protein per microarray spot was determined with Sypro
Ruby protein blot stain (Invitrogen/Molecular Probes) per
manufacturer’s directions and imaged with a CCD camera (Nova
Ray, Alpha Innotech, San Leandro, CA).
Tyrosine phosphatase activity
Human breast tissue organoids, containing breast epithelium,
adipose tissue and stromal elements, were cultured in serum-free
DMEM/F12 as previously described (Espina et al PloS One April
2010). Organoids of about 1-2 mm
3 size were removed from the
culture flask and fixed for 1, 5 or 15 minutes in 500 mL of either
10% neutral buffered formalin or BHP. After fixation each
organoid was washed 2 times in 1 mL of PBS (Gibco) to remove
residual fixative. 250–500 mL of non-denaturing extraction buffer
(20 mM Tris-HCl (pH 7.5) (Bio-Rad, Hercules, CA), 150 mM
NaCl (Thermo Fisher Scientific, Pittsburgh, PA), 1 mM EDTA
(Fluka, St. Louis, MO), 1 mM EGTA (Sigma-Aldrich, St. Louis,
MO)) was added to each organoid depending on organoid size.
Tissue was manually homogenized using a glass tissue grinder for
1 minute, followed by 1 minute of sonication. This process was
repeated 3 times and the homogenate spun at 14,000 x g for 10
minutes at 4uC. The supernatant was divided into aliquots and
frozen at 280uC until measurement.
Tyrosine phosphatase activity was measured using the Re-
diPlate 96 EnzChek Tyrosine Phosphatase Assay Kit (Invitrogen,
Carlsbad, CA) according to the manufacturer’s protocol. Samples
were measured in duplicate per assay and two independently
prepared samples/organoids were analyzed for each time point
and fixation type.
Evaluation of Protein Extractability
Following euthanasia with CO2, brain and liver from 10 week
old ICR/CDI mice (Harlan) were removed and sectioned into 4
pieces that were either snap-frozen in liquid nitrogen, fixed in
BHP for 1 day, fixed in BHP for 7 days, fixed in 10% neutral
buffered formalin (NBF) for 1 day or fixed in NBF for 7 days.
Fixed tissue was paraffin embedded and sectioned (5 mm
thickness). Snap frozen tissue was kept at 280uC until sectioning
in a cryostat (5 mm thickness). The tissue area was estimated by
outlining a representative image of a serial section of each sample
using a polygon drawing software option with the ArcturusXT
laser capture microdissection instrument (Life Technologies,
Carlsbad, CA) and calculating the resulting polygon area. Whole
tissue sections were scraped off with a clean razor blade and added
to a volume of extraction buffer based on the area of each tissue
section. Protein extraction was performed using extraction
protocol 1 and 2 (see above) and total protein content measured
using a Sypro Ruby Protein Blot stain of a reverse phase protein
microarray.
Immunohistochemistry
Formalin fixed (FFPE) or BHP-Tissue fixed, paraffin embedded
tissue sections (5 mm thickness) mounted on positively charged glass
slides were baked at 56uC for 30 min, deparaffinized in xylene and
rehydrated in a series of graded alcohols (100%, 95%, and 70%)
with a final rinse in wash buffer (Dako). Immunostaining post heat
induced epitope retrieval (for details on antibodies and respective
epitope retrieval methods see Table S6) was performed on a
Ventana BenchMarkslide stainerwith anUltraviewUniversalDAB
detection IVD kit (Ventana Medical System; samples 13–16 (Table
S7)), a Leica BOND-MAX with a Bond Polymer Refine Detection
kit (Leica Microsystems; sample 6 (Table S7)), or a Dako
Autostainer with an EnvisionSystem+HRP staining kit (Dako;
remaining samples (Table S7)) with development in diaminoben-
zidine or per manufacturer’s instructions. Tissue sections were
nuclear counterstained with Mayer’s hemalume (Kaltek Srl;
samples 13–16 (Table S7)), Harris Haematoxylin Acidified
Papanicolaou stain (Modification II, CellPath; sample 6 (Table
S7)), or hematoxylin (Dako; remaining samples (Table S7)) and
Scott’s Tap Water Substitute, and cover slips were applied with
aqueous mounting medium (Faramount, Dako).
Periodic Acid Schiff staining (Richard-Allan Scientific, Kala-
mazoo, MI) of FFPE and BHP fixed colon mucosa sections was
performed per manufacturer’s instructions. The HecepTest (Dako)
was performed according to the manufacturer’s instructions.
Images were captured with an Olympus BX51 microscope using
20x or 100x objectives.
To address the question of specificity for the increased staining
seen in BHP-fixed samples as compared to equivalent tissues fixed
in formalin we performed a protein competition assay with the
Dako HercepTest Her2 antibody. DCIS breast tissue of a 48 year
old female was collected after surgery and fixed for seven days in
BHP, followed by paraffin embedding. Directly following
deparaffinization, tissue sections were stained using the HercepT-
est kit (Dako). Very robust staining of the BHP-fixed as well as
formalin-fixed tissue made heat induced epitope retrieval unnec-
essary. The tissue was blocked for one hour with the HercepTest
kit rabbit serum IgG following the peroxidase block step. To
compete the antibody prior to staining ready-to-use Her2 antibody
from the kit was pre-incubated with 0.012 ng/ı `l full length
recombinant human Her2 protein (Origene) on a shaker at room-
temperature for three hours. Following incubation, the antibody-
protein mixture was centrifuged for 15 minutes at 16,000 g at
room-temperature and the supernatant used directly for immu-
nostaining following manufacturer’s directions. Non-competed
Her2 antibody was treated alongside the competed Her2 antibody
without addition of the Her2 protein and immunostaining with
both antibodies was performed side-by-side on a Dako Autostainer
(Dako) using the same staining protocol.
Comparison of nuclear size
Human colon mucosa and mouse brain, liver and pancreas
tissue was fixed in 10% neutral buffered formalin or BHP, paraffin
embedded and sections were de-paraffinized in xylene, rehydrated
in graded alcohol and stained with hematoxylin and eosin. Using
the Arcturus
XT(Life Technologies) polygon drawing software, the
area of 50 to 100 nuclei was measured per tissue and fixation type.
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Standard error of the mean (SEM) was calculated for individual
samples. The Mann-Whitney test was used to determine statistical
significance between fixation times (Figure 3), while Student’s t-test
was used to determine statistical significance between nuclear sizes
(Figure 9). P values ,0.05 were considered significant. Due to the
number of biological replicates (n=3) for the comparison of
phosphoprotein levels between BHP fixed and snap-frozen tissue
(Figure 4C) the significance of differences was estimated by the
amount of SEM overlap. Non-overlapping SEM was used as an
indicator of possible significant difference [50].
Supporting Information
Figure S1 Tissue size has no significant effect on
phosphoprotein preservation in BHP-fixed, paraffin-
embedded human colon mucosa. Human colon mucosa
was fixed for two days (A) or seven days (B) in BHP, followed by
paraffin embedding. After sectioning, the tissue area was measured
using the Arcturus
XT platform and protein extraction buffer added
to maintain a constant buffer/tissue area ratio. Protein extracts
were printed and the abundance of 11 phosphoproteins measured
using reverse phase protein microarrays. Relative phosphoprotein
abundance is plotted versus respective tissue area. No statistically
significant correlation (p.0.05) was found to exist between any
phosphoprotein and tissue area as measured by Spearman’s Rho
coefficient (Table S1).
(TIF)
Figure S2 HercepTest specificity in BHP-fixed human
breast DCIS as demonstrated by protein-antibody
competition assay. Herceptest specificity in BHP-fixed human
breast DCIS as demonstrated by protein competition assay. DCIS
breast tissue of a 48 year old female was collected after surgery and
fixed for seven days in BHP, followed by paraffin embedding.
Directly following deparaffinization, tissue sections were stained
using the HercepTest kit (Dako). Very robust staining of the BHP-
fixed as well as formalin-fixed tissue made heat induced epitope
retrieval unnecessary. The tissue was blocked for one hour with
the HercepTest kit rabbit serum IgG following the peroxidase
block step. To compete the antibody prior to staining ready-to-use
Her2 antibody from the kit was pre-incubated with 0.012 ng/ml
full length recombinant human Her2 protein (Origene) on a
shaker at room-temperature for three hours. Following incubation,
the antibody-protein mixture was centrifuged for 15 minutes at
16,000 g at room-temperature and the supernatant used directly
for immunostaining following manufacturer’s directions. Non-
competed Her2 antibody was treated alongside the competed
Her2 antibody without addition of the Her2 protein and
immunostaining with both antibodies was performed side-by-side
on a Dako Autostainer (Dako) using the same staining protocol.
No staining was visible after competing the Her2 antibody with full
length Her2, indicating that the increased staining seen in BHP-
fixed tissue compared to formalin fixation is specific.
(TIF)
Figure S3 Phospho-ERK Thr202/Tyr204 western blot of
frozen and BHP-fixed human colon mucosa. Human colon
mucosa was collected after surgery (colon a = male, colon b =
female) and snap frozen or fixed in BHP prior to paraffin
embedding. Following, samples were lysed and proteins separated
in a 4–20% Tris-Glycine gel (Invitrogen). After blotting the
membrane was stained using a phospho-ERK Thr202/Tyr204
antibody (Cell Signaling), stripped and re-probed with a beta actin
antibody (Cell Signaling). Lysates from BHP-fixed tissue demon-
strated the specific phospho-ERK double band (42/44 kDa) also
seen in the frozen sample.
(TIF)
Table S1 Spearman’s rho analysis of tissue size versus
phosphoprotein preservation in BHP-fixed, paraffin-
embedded human colon mucosa.
(DOC)
Table S2 Immunohistochemical Evaluation of Human
Colon Mucosa – Pathologist 1.
(DOC)
Table S3 Immunohistochemical Evaluation of Human
Colon Mucosa – Pathologist 2.
(DOC)
Table S4 Human/Animal tissues collected and fixed in
biomarker and histology preservative.
(DOC)
Table S5 Validated primary antibodies used for reverse
phase protein microarrays.
(DOC)
Table S6 Antibodies used for immunohistochemistry.
(DOC)
Table S7 Tissue sample identification and fixation
detail for each experimental procedure.
(XLS)
Text S1 Histology Description for H&E stained tissues
and Immunohistochemistry.
(DOC)
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